Home > Food & Beverages > Nutraceuticals > Coenzyme Q10 Market
Coenzyme Q10 Market size is estimated to record a CAGR of over 10.5% between 2023 and 2032. The growth is attributed to the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and lung diseases. As per CDC, around 60% of the American population clasps with at least one chronic disorder.
The increasing disease burden, in consort with rising healthcare expenditure is encouraging the consumers to look for relevant health supplements. Coenzyme Q10 (CoQ10) is well-known for enriching the heart health, increasing energy levels, and is a potential antioxidant. The inclination of individuals towards consuming supplements and other natural products to improve the quality of life is propelling the coenzyme Q10 market growth.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10.5% |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 110 |
Segments covered: | Application |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Further, the increasing geriatric population is also considered to be one of the major factors fueling the product demand. With the growing age, ability of body to produce or generate the compound decreases. As CoQ10 is important for producing cellular energy, elderly people are recommended to opt for these supplements to maintain strength and alleviate age-related chronic diseases.
The high expenditure related to the product manufacturing is one of the major factors hindering the coenzyme Q10 market expansion, restraining its ease of access to a vast consumer base. Furthermore, the numerous health supplement substitutes available deter the interest and investment away from CoQ10. This factor, along with various regulatory constraints related to dietary supplements in different regions that lead to irregularities are expected to restrain the industry growth.